Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Georgios Kalopitas"'
Autor:
Georgios Kalopitas, Konstantinos Arvanitakis, Olga Tsachouridou, Konstantinos Malandris, Theocharis Koufakis, Symeon Metallidis, Georgios Germanidis
Publikováno v:
Life, Vol 14, Iss 6, p 742 (2024)
Chronic liver disease is one of the main causes of morbidity and mortality in people living with HIV (PLWH). The increasing life expectancy of PLWH, effective treatment for viral hepatitis, and Western dietary patterns as well as the adverse effects
Externí odkaz:
https://doaj.org/article/999e89d4ac6c4b5380440473a5155fcb
Autor:
Serafeim Chrysovalantis Kotoulas, Katerina Manika, Georgios Pilianidis, Paulos Tsikouriadis, Georgios Kalopitas, Nikolaos Petridis, Athanasia Apsemidou, Avramidis Iakovos, Ioannis Kioumis
Publikováno v:
Breathe, Vol 15, Iss 2, Pp 121-127 (2019)
Externí odkaz:
https://doaj.org/article/566ec01447694ae98e6691fc6ebc5440
Publikováno v:
Viruses, Vol 13, Iss 10, p 2096 (2021)
The approval of combination therapies with direct-acting antiviral (DAA) regimens has led to significant progress in the field of hepatitis C virus (HCV) treatment. Although most patients treated with these agents achieve a virological cure, resistan
Externí odkaz:
https://doaj.org/article/b5bd8dec38694a1db5172d8b17982276
Autor:
Georgios Dionysopoulos, Georgios Kalopitas, Andreas Vadarlis, Dimitra Rafailia Bakaloudi, Nikolaos Gkiourtzis, Evangelia Karanika, Eirini Tsekitsidi, Michail Chourdakis
Publikováno v:
Critical Reviews in Food Science and Nutrition. :1-9
Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in children and no medications or supplements are currently recommended. The role of omega-3 (n-3) fatty acids has been investigated in clinical trials with pro
Autor:
Evangelia Karanika, Georgios Kalopitas, Michail Chourdakis, Andreas Vadarlis, Sofia Chantavaridou, Eirini Tsekitsidi, Dimitra Rafailia Bakaloudi
Publikováno v:
Clinical Nutrition. 41:105-121
Summary Background & Aims Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in children and one of the leading indications for liver transplantation in adults. However, current screening methods are inadequate and are accompa
Autor:
Nikolaos Petridis, Athanasia Apsemidou, Georgios Kalopitas, Georgios Pilianidis, Iakovos Avramidis
Publikováno v:
Case Reports in Infectious Diseases, Vol 2018 (2018)
Streptococcus thoraltensis has mainly been reported to cause infections in animals. Its clinical significance as a human pathogen has not yet been fully elucidated and needs further investigation. We describe here a case of bacteremia attributed to S
Externí odkaz:
https://doaj.org/article/e4e7ee613bf54c8792d63bc1c64c1989
Autor:
Panagiotis Skendros, Georgios Germanidis, Dimitrios C. Mastellos, Christina Antoniadou, Efstratios Gavriilidis, Georgios Kalopitas, Anna Samakidou, Angelos Liontos, Akrivi Chrysanthopoulou, Maria Ntinopoulou, Dionysios Kogias, Ioanna Karanika, Andreas Smyrlis, Dainora Cepaityte, Iliana Fotiadou, Nikoleta Zioga, Ioannis Mitroulis, Nikolaos K. Gatselis, Charalampos Papagoras, Simeon Metallidis, Haralampos Milionis, George N. Dalekos, Loek Willems, Barbro Persson, Vivek Anand Manivel, Bo Nilsson, E. Sander Connolly, Simona Iacobelli, Vasileios Papadopoulos, Rodrigo T. Calado, Markus Huber-Lang, Antonio M. Risitano, Despina Yancopoulou, Konstantinos Ritis, John D. Lambris
Publikováno v:
Science Advances. 8
Complement C3 activation contributes to COVID-19 pathology, and C3 targeting has emerged as a promising therapeutic strategy. We provide interim data from ITHACA, the first randomized trial evaluating a C3 inhibitor, AMY-101, in severe COVID-19 (PaO2
Autor:
Νikolaos Gkiourtzis, Georgios Kalopitas, Andreas Vadarlis, Dimitra Rafailia Bakaloudi, Georgios Dionysopoulos, Evangelia Karanika, Eirini Tsekitsidi, Michail Chourdakis
Publikováno v:
Journal of pediatric gastroenterology and nutrition. 75(3)
We conducted a systematic review and meta-analysis to provide a summary of the current literature about the efficacy of probiotics in pediatric nonalcoholic fatty liver disease (NAFLD).A systematic literature search through major electronic databases
Autor:
Xenophon Theodoridis, Georgios Kalopitas, Andreas Vadarlis, Dimitra Rafailia Bakaloudi, Νikolaos Gkiourtzis, Georgios Dionysopoulos, Evangelia Karanika, Eirini Tsekitsidi, Michail Chourdakis
Publikováno v:
Pharmacologytherapeutics. 240
The incidence of non-alcoholic fatty liver disease (NAFLD) in children is constantly rising. Lifestyle modification is the cornerstone of the management of pediatric NAFLD. Even though several clinical trials have been conducted, there are barely any
Autor:
Theofanis Maris, Theodoros Dardavessis, Michail Chourdakis, Ioannis Doundoulakis, Christina Antza, Georgios Kalopitas, Dimitra Rafailia Bakaloudi, Andreas Vadarlis, Myrto Samara
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:311-319
BACKGROUND AND AIM Νon-alcoholic fatty liver disease (NAFLD) is estimated to be the most common cause of end-stage liver disease in the next years. Vitamin E has shown beneficial effects as a possible "scavenger" of oxidative stress products, which